Marxsa schreef op 20 mei 2020 08:45:
Barbara retired from Merck & Co., Inc. in 2014 after 12 years as Vice President and Chief Licensing Officer. At Merck, Barbara and her licensing team successfully structured and negotiated agreements to acquire rights to over 150 compounds, programs and technologies
to enhance the pipeline.Koren op de molen v
an dpak, 'to enhance the pipeline"